BRN

0.00%

23.0¢ brainchip holdings ltd

2022 BRN Discussion, page-744

First 744 Last

Share
Profile

Follow
MarketingMan

5,844 Posts.

3483

07/01/22

18:27

Post #: 58714085
Share

Originally posted by sf120: ↑

The issue with valuing this company is the revenue for a hardware business isn't as exponential as a service business like apt. The revenue multiples one would pay is much lower for hardware business making it harder for brn to move on a purely fundamental basis. Revenue as well is going to be a challenge as they are truly 3 years ahead of the market, what would mercedes do with the chip tommorrow? Concepts are Great but hard revenue is due different.

What is does have going for it is the hype and headlines. Lots of partnership headlines to come and the stock will move on implied revenue when there is something tangible to show. This stock is also the talk of the town and no doubt some great posters on hotcopper help. A two sided sword given we are now paying for emotions and receiving emotional volatility, example does Mercedes using akida really warrant an additional 400m valuation?

I am a buyer in waiting. Do I regret not jumping in at 60c? Probably, but I find it nearly impossible to Find a valuation for this company leaving me only peer multiples;which are lacking but one can highlight Intel's purchase of Habana for 3b as a comparison on patents alone. The alternative is to get a sense for the share price and buy many times; thus leaving value once we smooth out the emotional premiums.

I hope to buy in at 78c, I guess I could be hoping for a long time! But the ship isn't leaving beyond fair future value for sometime.
16b in two years ? Sadly I think the will be bought out before, why Intel hasn't moved as yet is worth considering. They have a competing product, if brn has the better chip, 2b is nothing for Intel which is a 200b company.

Great company for those who can see it through..

Expand

I think you need to work harder to understand just how disruptive this technology is...

https://jwpm.com.au/industrial-marketing-blog/brn-brainchip-neuromorphic

BRN Price at posting: 97.0¢ Sentiment: Buy Disclosure: Held
44 Upvote

4 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 10,179 more messages in this thread...

First 744 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $451.3M

Open	High	Low	Value	Volume
23.0¢	24.0¢	21.5¢	$2.863M	12.69M

Buyers (Bids)

No.	Vol.	Price($)
6	136498	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	444756	13

View Market Depth

No.	Vol.	Price($)
4	86498	0.230
3	155000	0.225
16	439886	0.220
14	751341	0.215
35	871743	0.210

Price($)	Vol.	No.
0.235	360988	11
0.240	791244	17
0.245	612347	15
0.250	151787	5
0.255	132485	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

BRN (ASX) Chart

2022 BRN Discussion, page-744

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2022 BRN Discussion, page-744

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News